Centenial Surgical Suture Adjusts Evaluation Amid Profit Decline and Strong Long-Term Returns

Centenial Surgical Suture, a microcap company in the healthcare services industry, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a bullish stance to a mildly bullish outlook. The stock's current price stands at 144.50, slightly below its previous close of 145.55. Over the past year, Centenial has demonstrated a return of 23.50%, significantly outperforming the BSE500 index. However, the company has faced challenges, including a notable decline in profits, with a reported PBT less OI of Rs -1.39 crore and an EPS of Rs -3.23 for the latest quarter. Despite these hurdles, the stock maintains a very attractive valuation, indicated by a ROCE of 4.7 and a favorable enterprise value to capital employed ratio of 1.5. The company has also shown consistent returns over the past three years, with a remarkable 398.28% return over five years. Overall, the recent evaluation adjustment for Centenial Surgical Suture highlights the complexities of its market position and performance indicators. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.